Take me to the text The following financial statements are taken from the records of Organo Inc. a) Use horizontal analysis techniques to compare the changes between 2019 and 2018 balance sheet items. Do not enter dollar signs or commas in the input boxes. Use the negative sign for negative values, Round all answers to 2 decimal places. Organo Inc. Balance Sheet As at September 30 2019 2018 % Change Current Assets Cash $328,400 $315,700 Accounts Receivable $227,100 $187,800 Merchandise Inventory $381,300 $409,500 Short-Term Investments $127,600 $102,400 Total Current Assets $1,064,400 $1,015,400 Other Assets $195,800 $332,200 Total Assets $1,260,200 $1,347,600 Current Liabilities $271,700 $241,400 Long-Term Debt $185,600 $148,800 Total Liabilities $457,300 $390,200 % Shareholders' Equity $802,900 $957,400 9% Total Liabilities and Equity $1,260,200 $1,347,600b) Perform a vertical analysis of the income statement for 2019, stating all income statement items as a percentage of net sales. Organo Inc. Income Statement For the Year Ended September 30 2019 Sales $716,000 Cost of Goods Sold $250,600 X Gross Profit $465,400 Operating Expenses Advertising Expense $7,900 Bank Charges Expense $7,400 Communication Expense $6,100 Depreciation Expense $7,800 Professional Fees Expense $7,000 Rent Expense $5,900 Repairs and Maintenance Expense $5,700 Salaries and Wages Expense $55,300 Transportation Expense $6,200 X Utilities Expense $6,200 Total Operating Expenses $115,500 Net Income $349,900